Platelet Aggregation Prasugrel-upstream Therapy for NSTEMI without Benefit

被引：0
|
作者：
Feldmann, Christoph
机构：
来源：
AKTUELLE KARDIOLOGIE | 2014年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [21] Impact of Prasugrel Reload Dosing Regimens on High On-Treatment Platelet Reactivity Rates in Patients on Maintenance Prasugrel Therapy
    Luis Ferreiro, Jose
    Ueno, Masafumi
    Tello-Montoliu, Antonio
    Tomasello, Salvatore D.
    Seecheran, Naveen
    Desai, Bhaloo
    Rollini, Fabiana
    Guzman, Luis A.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (02) : 182 - 184
  • [22] Platelet inhibition with prasugrel: clinical relevance in therapy and prevention of coronary artery disease
    Gassanov, N.
    Caglayan, E.
    Nia, A. M.
    Erdmann, E.
    Er, F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (31-32) : 1542 - 1546
  • [23] Combination Therapy for Urticaria without Benefit
    Di Lorenzo, G.
    ALLERGO JOURNAL, 2005, 14 (01) : 13 - 13
  • [24] Prevalence of platelet aggregation defects in women with and without menorrhagia
    Knol, H. M.
    Mulder, A. B.
    Kluin-Nelemans, H. C.
    van der Zee, A.
    Bogchelman, D. B.
    Karina, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 341 - 341
  • [25] CONTINUOUS MEASUREMENT OF PLATELET-AGGREGATION WITHOUT ADDITION OF AGGREGATION INDUCING SUBSTANCES
    JAGER, W
    KUTSCHERA, J
    WENDEBERG, H
    KAUSCHMANN, R
    RIESE, W
    PIETSCH, U
    BERGER, E
    BENNERT, C
    BLUT, 1974, 29 (03): : 184 - 194
  • [26] PLATELET-AGGREGATION AFTER THROMBOLYTIC THERAPY
    GRIGUER, P
    BROCHIER, M
    LEROY, J
    LECLERC, MH
    ANTOINE, G
    BERTRAND, H
    CHALONS, F
    ANGIOLOGY, 1980, 31 (02) : 91 - 99
  • [27] Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects
    Jakubowski, Joseph A.
    Payne, Christopher D.
    Weerakkody, Govinda J.
    Brandt, John T.
    Farid, Nagy A.
    Li, Ying G.
    Naganuma, Hideo
    Lachno, D. Richard
    Winters, Kenneth J.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (03) : 167 - 173
  • [28] Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38
    Wiviott, Stephen D.
    Braunwald, Eugene
    Angiolillo, Dominick J.
    Meisel, Simha
    Dalby, Anthony J.
    Verheugt, Freek W. A.
    Goodman, Shaun G.
    Corbalan, Ramon
    Purdy, Drew A.
    Murphy, Sabina A.
    McCabe, Carolyn H.
    Antman, Elliott M.
    CIRCULATION, 2008, 118 (16) : 1626 - 1636
  • [29] Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor
    Siller-Matula, Jolanta M.
    Hintermeier, Anna
    Kastner, Johannes
    Kreiner, Gerhard
    Maurer, Gerald
    Kratochwil, Christoph
    Lang, Irene M.
    Delle-Karth, Georg
    VASCULAR PHARMACOLOGY, 2016, 79 : 6 - 10
  • [30] NORMALIZATION OF PLATELET AGGREGATION IN QUEBEC PLATELET DISORDER DURING ANTIFIBRINOLYTIC THERAPY
    Mathews, Natalie
    Tasneem, Subia
    Rivard, Georges-Etienne
    Hayward, Catherine P. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 77 - 77
12345